Stephen Gordon Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week ago
Stephen Gordon has an estimated net worth of at least $15.8 million*, as of Dec. 18, 2024. They own 21,299 shares of TMDX stock. They have sold 198,963 shares of TMDX stock since 2021, for an estimated $14.4 million.
Stephen Gordon $TMDX SEC Form 4 Insider Trading
Stephen Gordon has filed a total of 24 insider trades in $TMDX since 2021. Their most recent trade was a sale of 2,060 shares, made on Jun 03, 2024. Their largest trade was a sale of 15,000 shares, made on May 06, 2024. We estimate that they now own 21,299 shares of $TMDX, worth an estimated $1.4 million.
Insider Trading at $TMDX
There have been a total of 315 insider trades reported at $TMDX since 2021, with 102,500 shares purchased and 1.3 million shares sold. The most active insider traders in $TMDX stock have been Tamer I Khayal, Waleed H Hassanein, and John F Carey. The most recent trade was a sale of 1,084 shares reported by Tamer I Khayal (Chief Commercial Officer), made on Dec 02, 2024.
History of Insider Stock Trades by Stephen Gordon
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TMDX
|
Sale | 2,060 | Jun 03, 2024 | June 5, 2024, 5:12 p.m. |
|
TMDX
|
Sale | 8,655 | May 29, 2024 | May 31, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 9,345 | May 29, 2024 | May 31, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 2,000 | May 29, 2024 | May 31, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 15,000 | May 06, 2024 | May 8, 2024, 4:33 p.m. |
|
TMDX
|
Sale | 15,000 | Apr 01, 2024 | April 2, 2024, 5:28 p.m. |
|
TMDX
|
Sale | 1,903 | Mar 08, 2024 | March 12, 2024, 7:28 p.m. |
|
TMDX
|
Sale | 15,000 | Mar 04, 2024 | March 5, 2024, 7:20 p.m. |
|
TMDX
|
Sale | 15,000 | Feb 01, 2024 | Feb. 2, 2024, 7:56 p.m. |
|
TMDX
|
Sale | 5,000 | Oct 02, 2023 | Oct. 4, 2023, 5 p.m. |
|
TMDX
|
Sale | 5,000 | May 01, 2023 | May 2, 2023, 6:31 p.m. |
|
TMDX
|
Sale | 5,000 | Mar 01, 2023 | March 2, 2023, 6 p.m. |
|
TMDX
|
Sale | 5,000 | Feb 01, 2023 | Feb. 3, 2023, 6:06 p.m. |
|
TMDX
|
Sale | 5,000 | Jan 17, 2023 | Jan. 18, 2023, 7:02 p.m. |
|
TMDX
|
Sale | 31 | Dec 01, 2022 | Dec. 5, 2022, 6:30 p.m. |
|
TMDX
|
Sale | 9,969 | Dec 01, 2022 | Dec. 5, 2022, 6:30 p.m. |
|
TMDX
|
Sale | 10,000 | Nov 07, 2022 | Nov. 9, 2022, 6 p.m. |
|
TMDX
|
Sale | 10,000 | Oct 03, 2022 | Oct. 4, 2022, 12:33 p.m. |
|
TMDX
|
Sale | 10,000 | Sep 01, 2022 | Sept. 2, 2022, 5 p.m. |
|
TMDX
|
Sale | 10,000 | Aug 08, 2022 | Aug. 9, 2022, 2 p.m. |
|
TMDX
|
Sale | 10,000 | Jul 05, 2022 | July 6, 2022, 6:19 p.m. |
|
TMDX
|
Sale | 10,000 | Sep 07, 2021 | Sept. 8, 2021, 8 p.m. |
|
TMDX
|
Sale | 10,000 | Jul 15, 2021 | July 15, 2021, 8 p.m. |
|
TMDX
|
Sale | 10,000 | Jun 17, 2021 | June 20, 2021, 8 p.m. |
$TMDX Executives and Stock Owners with Insider Trades
-
Tamer I Khayal, Chief Commercial Officer
-
Waleed H Hassanein, President & CEO
-
John F Carey, VP of Operations
-
Stephen Gordon, Chief Financial Officer
-
Miriam Provost, VP, Global Regulatory Affairs
-
Laura Damme, VP, Clinical Affairs
-
Anil P. Ranganath, See remarks
-
Nicholas Corcoran, See Remarks
-
Miriam Provost, VP of US Regulatory & FDA Rel.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.